About: Saratoga Opthalmology

Posts by Saratoga Opthalmology:

FDA approves aflibercept for diabetic retinopathy

Aflibercept is now an approved treatment for all stages of diabetic retinopathy (DR), making it the only anti-VEGF agent with two dosing options for DR. Source: AAO

Posted on: May 15 2019
By: Saratoga Opthalmology
Leave a reponse

Can tropicamide be omitted from pediatric dilation drops?

In this study, researchers assessed the cycloplegic and mydriatic effects of omitting tropicamide from a common pediatric eye drop combination. Source: AAO

Posted on: May 15 2019
By: Saratoga Opthalmology
Leave a reponse

Oral spironolactone offers an alternative for chronic CSR

Investigators retrospectively compared visual and anatomical outcomes among chronic central serous chorioretinopathy (CSR) patients treated with oral spironolactone or half-dose photodynamic therapy (PDT). Source: AAO

Posted on: May 14 2019
By: Saratoga Opthalmology
Leave a reponse

CMV corneal endotheliitis after DMEK can mimic graft injection

This is the first report of cytomegalovirus (CMV) corneal endotheliitis after Descemet membrane endothelial keratoplasty (DMEK). Source: AAO

Posted on: May 13 2019
By: Saratoga Opthalmology
Leave a reponse

Novartis to acquire dry eye drug lifitegrast

The prescription dry eye treatment lifitegrast (Xiidra) will change hands from Takeda to Novartis later this year, at an estimated cost of $5.3 billion. Source: AAO

Posted on: May 13 2019
By: Saratoga Opthalmology
Leave a reponse

Retinal imaging platform wins FDA breakthrough designation

Optina Diagnostics has received the breakthrough device designation for their retinal scanner designed to aid in the early detection of Alzheimer disease. Source: AAO

Posted on: May 13 2019
By: Saratoga Opthalmology
Leave a reponse

Week in review: Suitcase alarm, DNase drop, RingJect redo

This week, a collision-detecting suitcase helps blind people navigate airports, an enzyme-based drop soothes dry eyes and an Ophtec capsular tension ring injector gets a design overhaul. Source: AAO

Posted on: May 10 2019
By: Saratoga Opthalmology
Leave a reponse

Observation a reasonable strategy for patients with DME and good vision

In this study, researchers compared 3 strategies for managing eyes with center-involved diabetic macular edema (DME): aflibercept, laser photocoagulation and observation. Source: AAO

Posted on: May 10 2019
By: Saratoga Opthalmology
Leave a reponse

Baseline vision often predictive of final visual outcomes in IIH

This paper explores whether mean deviations in visual field recorded at diagnosis can predict visual outcomes in idiopathic intracranial hypertension (IIH). Source: AAO